82_FR_23376 82 FR 23279 - National Institute of Diabetes and Digestive and Kidney Diseases: Notice of Closed Meetings

82 FR 23279 - National Institute of Diabetes and Digestive and Kidney Diseases: Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 97 (May 22, 2017)

Page Range23279-23279
FR Document2017-10279

Federal Register, Volume 82 Issue 97 (Monday, May 22, 2017) 
[Federal Register Volume 82, Number 97 (Monday, May 22, 2017)]
[Notices]
[Page 23279]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-10279]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases: 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; NIDDK Ancillary Studies.
    Date: June 9, 2017.
    Time: 11:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Elena Sanovich, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7351, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301-
594-8886, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel, R13 Conference Grant 
Applications.
    Date: June 22, 2017.
    Time: 11:00 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Jian Yang, Ph.D., Scientific Review Officer, 
Review Branch, DEA, NIDDK, National Institutes of Health, Room 7111, 
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-7799, 
[email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Continuation of the 
Preventing Early Renal Loss in Diabetes (PERL) Study (UC4).
    Date: June 22, 2017.
    Time: 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Jason D. Hoffert, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7343, 6707 Democracy Boulevard, Bethesda, MD 20817, 301-496-
9010, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Clinical Nephrology 
Small Business Applications.
    Date: June 22, 2017.
    Time: 2:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Ryan G. Morris, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7015, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301-
594-4721, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; RFA-DK-17-003: 
Therapeutic Targeting of the Human Islet Environment (UC4).
    Date: June 23, 2017.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Dianne Camp, Ph.D., Scientific Review Officer, 
Review Branch, DEA, NIDDK, National Institutes of Health, Room 7013, 
6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301-5947682, 
[email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; RFA-DK-17-004: 
Competitive Collaborative Projects for Human Islet Biology (UC4).
    Date: July 6, 2017.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: Residence Inn Downtown, 7355 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Najma Begum, Ph.D., Scientific Review Officer, 
Review Branch, DEA, NIDDK, National Institutes of Health, Room 7349, 
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-8894, 
[email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special, Emphasis Panel; Developmental Centers 
in Benign Urology (P20).
    Date: July 19, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Renaissance Arlington Capital View Hotel, 2800 South 
Potomac Ave, Arlington, VA 22202.
    Contact Person: Jason D. Hoffert, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7343, 6707 Democracy Boulevard, Bethesda, MD 20817, 301-496-
9010, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)


    Dated: May 16, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-10279 Filed 5-19-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 97 / Monday, May 22, 2017 / Notices 23279 Place: National Institutes of Health, 6701 Time: 11:00 a.m. to 12:30 p.m. Time: 8:00 a.m. to 6:00 p.m. Rockledge Drive, Bethesda, MD 20892 Agenda: To review and evaluate grant Agenda: To review and evaluate (Virtual Meeting). applications. cooperative agreement applications. Contact Person: Dimitrios Nikolaos Place: National Institutes of Health, Two Place: Residence Inn Downtown, 7355 Vatakis, Ph.D., Scientific Review Officer, Democracy Plaza, 6707 Democracy Wisconsin Avenue, Bethesda, MD 20814. Center for Scientific Review, National Boulevard, Bethesda, MD 20892 (Telephone Contact Person: Najma Begum, Ph.D., Institutes of Health, 6701 Rockledge Drive, Conference Call). Scientific Review Officer, Review Branch, Room 3190, Bethesda, MD 20892, 301–827– Contact Person: Jian Yang, Ph.D., Scientific DEA, NIDDK, National Institutes of Health, 7480. Review Officer, Review Branch, DEA, Room 7349, 6707 Democracy Boulevard, (Catalogue of Federal Domestic Assistance NIDDK, National Institutes of Health, Room Bethesda, MD 20892–5452, (301) 594–8894, Program Nos. 93.306, Comparative Medicine; 7111, 6707 Democracy Boulevard, Bethesda, begumn@niddk.nih.gov. 93.333, Clinical Research, 93.306, 93.333, MD 20892–5452, (301) 594–7799, yangj@ Name of Committee: National Institute of 93.337, 93.393–93.396, 93.837–93.844, extra.niddk.nih.gov. Diabetes and Digestive and Kidney Diseases 93.846–93.878, 93.892, 93.893, National Name of Committee: National Institute of Special, Emphasis Panel; Developmental Institutes of Health, HHS) Diabetes and Digestive and Kidney Diseases Centers in Benign Urology (P20). Dated: May 16, 2017. Special Emphasis Panel; Continuation of the Date: July 19, 2017. Preventing Early Renal Loss in Diabetes Time: 8:00 a.m. to 5:00 p.m. Natasha M. Copeland, (PERL) Study (UC4). Agenda: To review and evaluate grant Program Analyst, Office of Federal Advisory Date: June 22, 2017. applications. Committee Policy. Time: 1:00 p.m. to 2:00 p.m. Place: Renaissance Arlington Capital View [FR Doc. 2017–10272 Filed 5–19–17; 8:45 am] Agenda: To review and evaluate grant Hotel, 2800 South Potomac Ave, Arlington, BILLING CODE 4140–01–P applications. VA 22202. Place: National Institutes of Health, Two Contact Person: Jason D. Hoffert, Ph.D., Democracy Plaza, 6707 Democracy Scientific Review Officer, Review Branch, DEPARTMENT OF HEALTH AND Boulevard, Bethesda, MD 20892 (Telephone DEA, NIDDK, National Institutes of Health, Conference Call). Room 7343, 6707 Democracy Boulevard, HUMAN SERVICES Contact Person: Jason D. Hoffert, Ph.D., Bethesda, MD 20817, 301–496–9010, Scientific Review Officer, Review Branch, hoffertj@niddk.nih.gov. National Institutes of Health DEA, NIDDK, National Institutes of Health, (Catalogue of Federal Domestic Assistance Room 7343, 6707 Democracy Boulevard, Program Nos. 93.847, Diabetes, National Institute of Diabetes and Bethesda, MD 20817, 301–496–9010, Endocrinology and Metabolic Research; Digestive and Kidney Diseases: Notice hoffertj@niddk.nih.gov. of Closed Meetings 93.848, Digestive Diseases and Nutrition Name of Committee: National Institute of Research; 93.849, Kidney Diseases, Urology Pursuant to section 10(d) of the Diabetes and Digestive and Kidney Diseases and Hematology Research, National Institutes Federal Advisory Committee Act, as Special Emphasis Panel; Clinical Nephrology of Health, HHS) amended (5 U.S.C. App.), notice is Small Business Applications. Date: June 22, 2017. Dated: May 16, 2017. hereby given of the following meetings. Time: 2:00 p.m. to 4:00 p.m. David Clary, The meetings will be closed to the Agenda: To review and evaluate grant public in accordance with the Program Analyst, Office of Federal Advisory applications. provisions set forth in sections Committee Policy. Place: National Institutes of Health, Two 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Democracy Plaza, 6707 Democracy [FR Doc. 2017–10279 Filed 5–19–17; 8:45 am] as amended. The grant applications and Boulevard, Bethesda, MD 20892 (Telephone BILLING CODE 4140–01–P the discussions could disclose Conference Call). confidential trade secrets or commercial Contact Person: Ryan G. Morris, Ph.D., property such as patentable material, Scientific Review Officer, Review Branch, DEPARTMENT OF HEALTH AND and personal information concerning DEA, NIDDK, National Institutes of Health, HUMAN SERVICES Room 7015, 6707 Democracy Boulevard, individuals associated with the grant Bethesda, MD 20892–2542, 301–594–4721, applications, the disclosure of which National Institutes of Health ryan.morris@nih.gov. would constitute a clearly unwarranted Name of Committee: National Institute of National Center for Advancing invasion of personal privacy. Diabetes and Digestive and Kidney Diseases Translational Sciences; Notice of Name of Committee: National Institute of Special Emphasis Panel; RFA–DK–17–003: Closed Meeting Diabetes and Digestive and Kidney Diseases Therapeutic Targeting of the Human Islet Special Emphasis Panel; NIDDK Ancillary Environment (UC4). Pursuant to section 10(d) of the Studies. Date: June 23, 2017. Federal Advisory Committee Act, as Date: June 9, 2017. Time: 11:00 a.m. to 5:00 p.m. amended (5 U.S.C. App.), notice is Time: 11:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant hereby given of the following meeting. Agenda: To review and evaluate grant applications. The meeting will be closed to the applications. Place: National Institutes of Health, Two Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy public in accordance with the Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone provisions set forth in sections Boulevard, Bethesda, MD 20892 (Telephone Conference Call). 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Conference Call). Contact Person: Dianne Camp, Ph.D., as amended. The grant applications and Contact Person: Elena Sanovich, Ph.D., Scientific Review Officer, Review Branch, the discussions could disclose Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, confidential trade secrets or commercial DEA, NIDDK, National Institutes of Health, Room 7013, 6707 Democracy Boulevard, property such as patentable material, mstockstill on DSK30JT082PROD with NOTICES Room 7351, 6707 Democracy Boulevard, Bethesda, MD 20892–2542, 301–5947682, and personal information concerning Bethesda, MD 20892–2542, 301–594–8886, campd@extra.niddk.nih.gov. individuals associated with the grant sanoviche@mail.nih.gov. Name of Committee: National Institute of applications, the disclosure of which Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases would constitute a clearly unwarranted Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; RFA–DK–17–004: Special Emphasis Panel, R13 Conference Competitive Collaborative Projects for invasion of personal privacy. Grant Applications. Human Islet Biology (UC4). Name of Committee: National Center for Date: June 22, 2017. Date: July 6, 2017. Advancing Translational Sciences Special VerDate Sep<11>2014 23:17 May 19, 2017 Jkt 241001 PO 00000 Frm 00110 Fmt 4703 Sfmt 4703 E:\FR\FM\22MYN1.SGM 22MYN1


Document Created: 2018-11-08 08:50:08
Document Modified: 2018-11-08 08:50:08
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJune 9, 2017.
FR Citation82 FR 23279 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR